Erasca Stock Surges After Analyst Upgrade and Clinical Data Presentation
Erasca Inc. shares jumped over 20% to a multi-year high after HC Wainwright raised its price target to $11. The move followed the company's presentation of preliminary clinical data at a healthcare conference.